Table 2.
Overall survival and cancer-specific survival by therapeutic modality, adapted from Culp et al. (2014) [13].
| Therapeutic modality | 5-year OS rate (%) | 5-year CSS rate (%) |
|---|---|---|
| RP | 67,4 | 75,8 |
| BT | 52,6 | 61,3 |
| NLT | 22,5 | 48,7 |
OS: overall survival; CSS: cancer-specific survival; RP: radical prostatectomy; BT: brachytherapy; NLT: no local treatment.